Highlights from the Q2 2026 Report

• Quarterly Report Filed: Core Laboratories Inc. has released its Form 10-Q for the quarter ended June 30, 2026. The company remains fully compliant with SEC reporting requirements and is classified as a large accelerated filer.
• Business Address: Headquarters located at 6316 Windfern Road, Houston, TX 77040. No changes in fiscal year or address since last report.
• Common Stock Details: The company’s common stock is traded under the symbol “CLB” on the New York Stock Exchange.
• Shares Outstanding: As of the latest reporting date, Core Laboratories Inc. has 45,884,542 shares outstanding.

Financial Position Overview

Balance Sheet Snapshot (as of June 30, 2026)

• Total Current Assets: \$214.4 million
• Other Current Assets: \$6.9 million
• Intangible Assets (Excluding Goodwill): \$6.8 million
• Deferred Income Tax Assets: \$70.6 million
• Other Noncurrent Assets: \$36.0 million
• Total Assets: The double-line presentation indicates a robust asset base, though the precise total is not directly shown.

Liabilities Overview

• Current Liabilities: \$101.1 million
• Current Contract Liabilities: \$5.6 million
• Taxes Payable (Current): \$4.3 million
• Long-Term Debt and Capital Lease Obligations: \$110.3 million
• Deferred Income Tax Liabilities: \$7.6 million
• Other Long-Term Liabilities: Not itemized, but included in the balance sheet.

Equity Structure

• Preferred Stock: 6,000,000 shares authorized (\$0.01 par value), but none issued or outstanding.
• Common Stock: 200,000,000 shares authorized (\$0.01 par value), 46,966,868 shares issued and 46,095,379 shares outstanding at year-end 2025. As of June 30, 2026, 45,884,542 shares outstanding.
• Common Stock Value: \$470,000
• Additional Paid-In Capital: \$115.5 million
• Retained Earnings: \$176.9 million
• Treasury Stock: 871,489 shares at 2026 and 2025, valued at \$14.5 million (2026) and \$11.6 million (2025), respectively.
• Accumulated Other Comprehensive Income (Loss): Not itemized, but present.

Key Investor Considerations & Potential Price Sensitivity

• Debt Levels: The company maintains over \$110 million in long-term debt, which may affect interest expense and future cash flows.
• Share Count: The decrease in shares outstanding from 46,095,379 (2025) to 45,884,542 (June 2026) suggests potential share repurchases or buybacks, which often support share prices.
• Treasury Stock Increase: The value of treasury stock has increased by nearly \$3 million in six months, indicating active management of share capital, possibly repurchases.
• Retained Earnings Growth: Retained earnings are up, which may signal profitability and potential for future dividends.
• Compliance and Filing Status: The company is not a shell company and has submitted all required electronic filings, reducing regulatory risk.
• No Preferred Shares Outstanding: No dilution risk from preferred stock.
• Shareholder Equity: Equity remains strong, with substantial retained earnings and paid-in capital, supporting long-term stability.
• SEC Registration: Common stock remains actively traded on NYSE, ensuring liquidity for investors.

Potential Price Sensitive Factors: The active share repurchase program and increase in treasury stock, combined with healthy retained earnings and compliance as a large accelerated filer, are positive signals. However, high debt levels and the stable but not growing asset base may temper optimism. Investors should watch for further details in the full financial statements regarding cash flow, profitability, and any management commentary on outlook or risks.

Additional Information for Shareholders

• Legal and Regulatory: No indication of legal or regulatory issues in the report.
• Stockholder Rights: No change in fiscal year or registered address, maintaining corporate stability.
• Dividends: No explicit dividend announcement in this summary, but increased retained earnings may suggest future dividend capacity.
• Market Risk: Investors should review Item 3 in the full report for quantitative and qualitative disclosures about market risk.
• Management Discussion & Analysis: Detailed analysis is available from page 20 onward; investors should review these sections for commentary on business conditions and outlook.

Conclusion

Core Laboratories Inc. continues to show financial stability with robust retained earnings, active share management, and compliance with SEC requirements. The increase in treasury stock and decrease in shares outstanding could be bullish for share price, particularly if buybacks continue. Debt levels remain high, so investors should monitor future interest expenses and cash flow statements. No major negative surprises or legal concerns have surfaced in this quarter’s report, supporting a neutral-to-positive outlook barring any unforeseen developments in the detailed MD&A or cash flow analysis.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors should consult the full Form 10-Q and additional disclosures, and consider their own financial situation and risk tolerance before making investment decisions. Past performance is not indicative of future results. The author assumes no responsibility for actions taken based on this article.